Key Takeaways
- Remnant cholesterol sits in leftover fat carriers after triglycerides get removed.
- LDL can look fine while remnant particles stay high.
- Nonfasting tests can show remnant load during real life meals.
- Insulin resistance and fatty liver often raise remnant cholesterol.
- Fewer meals and fewer carbs can reduce after meal lipid traffic.
What Is Remnant Cholesterol
Cholesterol In Leftover Carriers
Remnant cholesterol is not a new type of cholesterol. It is the cholesterol sitting inside leftover fat carrying particles after much of their triglyceride load has been stripped away. Blood uses lipoproteins to move fat, because fat does not mix with water.
Two lipoproteins feed most remnants:
- chylomicrons from the gut after eating
- VLDL from the liver
As these particles travel, enzymes remove triglycerides for fuel or storage, and the particles shrink into remnants. The cholesterol still inside those smaller leftovers is called remnant cholesterol. ( Nordestgaard, 2016 )
Why LDL Can Miss The Story
LDL cholesterol refers to cholesterol carried in LDL particles. Remnant cholesterol refers to cholesterol carried in remnant particles, mainly chylomicron remnants and VLDL remnants. A person can have LDL that looks acceptable while still carrying a high load of remnants, especially when triglycerides run high after meals.
Many researchers focus on remnants because these particles are small enough to enter the artery wall more easily than full size chylomicrons. Once inside, cholesterol can be left behind and add to plaque growth. ( Nordestgaard and Varbo, 2014 )
How It Is Estimated
Many lab reports do not print remnant cholesterol as its own result. In research and in some clinics, it is often estimated from a standard lipid panel. ( Varbo et al., 2014 )
- Simple estimate: total cholesterol − HDL cholesterol − LDL cholesterol
- This is an estimate, so different LDL methods can shift the number.
Where Remnant Cholesterol Comes From
After A Meal
After eating fat, the small intestine builds chylomicrons to move triglycerides through the blood. As triglycerides are delivered to tissues, chylomicrons shrink and become remnants.
If the liver clears those remnants quickly, they do not linger long. If clearance is slow, remnant particles stay in the blood longer and the remnant cholesterol number rises.
This is one reason remnants are often discussed with nonfasting blood work. Remnants are active during the after meal window, which is how most people live most days.
From The Liver
The liver also ships fat out as VLDL particles. VLDL output often rises when the liver is overstuffed with energy, when insulin resistance is present, or when fatty liver develops. As VLDL loses triglycerides, it becomes smaller remnants and can later feed into other particle types. ( Nordestgaard, 2016 ) Remnant cholesterol can reflect both gut handling after meals and liver fat traffic across the day. That mix explains why it can stay high even when one headline number looks fine.
Why It Stays High
Remnant cholesterol rises when triglyceride rich particles are made in large amounts, cleared too slowly, or both. Insulin resistance often pushes both sides of the problem by raising liver output and weakening clearance. Guidance papers on triglyceride rich lipoproteins discuss this cluster in people at high risk, even when LDL alone fails to explain it. ( Chapman et al., 2011 )
What The Research Shows
Heart & Stroke Links
Large population studies have linked higher remnant cholesterol with higher risk of ischemic heart disease. Some analyses also use genetic methods to argue that remnant cholesterol is more than a side marker. ( Varbo et al., 2013 )
Other work has linked remnant cholesterol with ischemic stroke in large community samples. ( Varbo and Nordestgaard, 2019 ). These studies are useful, yet they still have limits. They often assume that lowering a marker in one way will lower outcomes the same way, which is not always true in real life.
They also tend to fold diet into broad categories that hide key details, such as seed oil intake, meal spacing, and the difference between refined carbs and whole animal foods.
Inflammation Signals
Some research links higher remnant cholesterol with markers of low grade inflammation. In one large dataset, remnant cholesterol tracked with both ischemic heart disease and inflammation markers, while LDL behaved differently. ( Varbo et al., 2013 ) Inflammation is a broad label, and blood markers can rise for many reasons. Still, this line of work helps explain why remnants get attention beyond triglycerides alone.
Beyond LDL & ApoB
In primary prevention research, remnant cholesterol has predicted cardiovascular disease beyond LDL cholesterol and apolipoprotein B patterns in some groups. ( Quispe et al., 2021 ) That does not mean LDL is useless. It means one number rarely captures a whole traffic jam of particles moving in different ways.
How To Lower Remnant Cholesterol
Meal Spacing
Remnant particles rise after meals, so eating frequency can stretch the after meal window across the whole day. One to three meals per day, with no grazing, gives the body time to clear particles before the next wave arrives.
This is not about willpower games. It is about giving the liver and blood enzymes a cleaner schedule to work with, so fewer remnants hang around for longer.
Lower Carb Intake
Carbs often drive high triglycerides in people with insulin resistance, especially when the carbs come from sugar and refined starch. When triglyceride rich particles rise, remnant cholesterol often rises with them. A lower carb approach can reduce the need for the liver to package and ship triglycerides as VLDL. ( Nordestgaard, 2016 )
An animal based, higher fat approach often makes this easier because fat and protein tend to hold appetite steady, which supports meal spacing. Animal fats can also help people avoid the low fat trap that leads to constant hunger and constant snacking.
Fiber is often treated like a must have, yet it is not essential for survival, and many people do well with little to no added plant roughage. If plant foods are used, choosing lower toxin options in small amounts can reduce gut stress for many people. Grains and many high oxalate, high lectin, and high phytate foods can be a poor fit for some, especially when digestion is already shaky.
Seed Oils & Ultra Processed Foods
Seed oils and ultra-processed foods often combine fragile industrial fats with refined carbs, flavors, and additives that make overeating easy. That mix can push liver fat traffic and worsen insulin resistance over time, which can raise VLDL output and remnants. Whole foods simplify the input signals. Ruminant meat, eggs, full fat dairy and minimally processed seafood often work well for people trying to lower triglycerides and stabilize meals. Alcohol can also raise liver triglyceride output in many people, so cutting it back can be an important lever.
Before changing your diet, supplements, or health routine, talk with a licensed healthcare professional. For any health concerns or questions about a medical condition, get guidance from a physician or another appropriately trained clinician.
FAQs
What is remnant cholesterol in simple terms?
Remnant cholesterol is the cholesterol left inside certain fat carrying particles after much of their triglyceride has been removed.
How do you calculate remnant cholesterol from a lipid panel?
A common estimate subtracts HDL and LDL from total cholesterol, using the same units as the lab report.
Can remnant cholesterol be high with normal LDL?
Yes. Remnants can run high when triglycerides are high or when clearance is slow, even if LDL looks fine.
Does fasting matter for remnant cholesterol?
Remnants often rise after meals, so nonfasting tests can show useful information that fasting may hide.
What food changes often help lower remnant cholesterol?
Many people do best with fewer meals, fewer carbs, more animal based fats, and fewer ultra-processed foods.
Research
Nordestgaard, B.G. (2016) ‘Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology’, Circulation Research, 118(4), pp.547–563. Nordestgaard, 2016
Nordestgaard, B.G. and Varbo, A. (2014) ‘Triglycerides and cardiovascular disease’, The Lancet, 384(9943), pp.626–635. Nordestgaard and Varbo, 2014
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A.B., Frikke-Schmidt, R. and Nordestgaard, B.G. (2013) ‘Remnant cholesterol as a causal risk factor for ischemic heart disease’, Journal of the American College of Cardiology, 61(4), pp.427–436. Varbo et al., 2013
Varbo, A. and Nordestgaard, B.G. (2019) ‘Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population’, Annals of Neurology, 85(4), pp.550–559. Varbo and Nordestgaard, 2019
Varbo, A., Benn, M., Tybjærg-Hansen, A. and Nordestgaard, B.G. (2013) ‘Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation’, Circulation, 128(12), pp.1298–1309. Varbo et al., 2013
Quispe, R., Martin, S.S., Michos, E.D., Lamba, I., Blumenthal, R.S., Saeed, A. and Elshazly, M.B. (2021) ‘Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study’, European Heart Journal, 42(42), pp.4324–4332. Quispe et al., 2021
Varbo, A., Benn, M. and Nordestgaard, B.G. (2014) ‘Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment’, Pharmacology & Therapeutics, 141(3), pp.358–367. Varbo et al., 2014
Chapman, M.J., Ginsberg, H.N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A.L., Descamps, O.S., Fisher, E., Kuivenhoven, J.A., Lesnik, P., Masana, L., Nordestgaard, B.G., Ray, K.K., Reiner, Ž., Taskinen, M.R. and Tokgözoğlu, L. (2011) ‘Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management’, European Heart Journal, 32(11), pp.1345–1361. Chapman et al., 2011
Langsted, A., Freiberg, J.J. and Nordestgaard, B.G. (2008) ‘Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction’, Circulation, 118(20), pp.2047–2056. Langsted et al., 2008
Nordestgaard, B.G., Benn, M., Schnohr, P. and Tybjærg-Hansen, A. (2007) ‘Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women’, JAMA, 298(3), pp.299–308. Nordestgaard et al., 2007
Bansal, S., Buring, J.E., Rifai, N., Mora, S., Sacks, F.M. and Ridker, P.M. (2007) ‘Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women’, JAMA, 298(3), pp.309–316. Bansal et al., 2007
Jepsen, A.M.K., Langsted, A., Varbo, A., Bang, L.E., Kamstrup, P.R. and Nordestgaard, B.G. (2016) ‘Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease’, Clinical Chemistry, 62(4), pp.593–604. Jepsen et al., 2016
Duran, E.K., Pradhan, A.D., Paynter, N.P., Glynn, R.J. and Ridker, P.M. (2020) ‘Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease’, Journal of the American College of Cardiology, 75(17), pp.2122–2135. Duran et al., 2020
Bonfiglio, C., Fabris, C., D’Errico, V. and Caviglia, G.P. (2020) ‘Remnant cholesterol as a risk factor for cardiovascular, cancer or other causes mortality: a competing risks analysis’, Nutrition, Metabolism and Cardiovascular Diseases, 30(12), pp.2098–2108. Bonfiglio et al., 2020
Castañer, O., Pintó, X., Subirana, I., Amor, A.J., Ros, E., Hernáez, Á., Martínez-González, M.Á., Corella, D., Salas-Salvadó, J., Estruch, R., Arós, F., Serra-Majem, L., Fiol, M., Sorlí, J.V., Gómez-Gracia, E., Díez-Espino, J., Lahoz, C., Lapetra, J., Muñoz, M.Á., Zazpe, I., Ruiz-Canela, M., Tojal-Sierra, L., Fitó, M. and Marrugat, J. (2020) ‘Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease’, Journal of the American College of Cardiology, 76(23), pp.2712–2724. Castañer et al., 2020
Doi, T., Langsted, A., Nordestgaard, B.G. and others (2022) ‘Elevated remnant cholesterol reclassifies risk of ischemic heart disease and myocardial infarction’, Journal of the American College of Cardiology, 79(24), pp.2383–2397. Doi et al., 2022
Langsted, A., Madsen, C.M. and Nordestgaard, B.G. (2020) ‘Contribution of remnant cholesterol to cardiovascular risk’, Journal of Internal Medicine, 288(1), pp.116–127. Langsted et al., 2020
Zhang, K., Liu, Y., Li, Y. and others (2022) ‘Remnant cholesterol is associated with cardiovascular mortality’, Frontiers in Cardiovascular Medicine, 9, p.984711. Zhang et al., 2022
Weaver, O.R., Hemmelgarn, B.R., Tonelli, M. and others (2023) ‘Nonfasting remnant cholesterol and cardiovascular disease risk prediction in Albertans: a prospective cohort study’, CMAJ Open, 11(4), pp.E645–E653. Weaver et al., 2023
